Skip to content

Clinical trials

Phase 3 Stroke trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20051
20061
20072
20081
20091
20101
20112
20132
20143
20182
20191
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting2
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Novartis Pharmaceuticals3
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan3
Bayer2
GlaxoSmithKline2
AstraZeneca1
CSL Behring1
Daiichi Sankyo1
Eli Lilly and Company1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke24
Myocardial Infarction7
Cardiovascular Diseases5
Ischemic Stroke5
Atrial Fibrillation4
Brain Ischemia4
Heart Diseases4
Acute Coronary Syndrome3
Coronary Artery Disease3
Hypercholesterolemia3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.